250 / 464
250
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
ELECTRONIC POSTERS
> Impact of concomitant radiotherapy boost in locally advanced rectal
cancer: dose escalation
M.A. Estornell (Spain), D. Martinez, V. Morillo, M. López, M. Soler,
J.L. Monroy, A.V. Navarro, A. Soler-Rodriguez
EP-1274
> Patients with locally advanced rectal cancer (LARC): predictive factors
of pathological response
S. Montrone (Italy), A. Sainato, R. Morganti, C. Vivaldi, B. Manfredi,
C. Laliscia, M. Cantarella, G. Coraggio, G. Musettini, A. Gonnelli,
G. Masi, P. Buccianti, F. Pasqualetti, F. Paiar
EP-1275
> Clinic and radiobiology of hypofractionated radiotherapy for metastatic
liver tumors. Pilot results.
T. Latusek (Poland), L. Miszczyk, J. Rembak-Szynkiewicz
EP-1276
> Optimising RT dose for anal cancer – the development of three clinical
trials in one platform
D. Sebag-Montefiore (UK), R. Adams, S. Bell, L. Berkman, D. Gilbert,
R. Glynne-Joones, V. Goh, W. Gregory, M. Harrison, L. Kachnic,
M. Lee, L. McParland, R. Muirhead, B. O’Neil, G. Hutchins, S. Rao,
A. Renehan, A. Smith, G. Velikova, M. Hawkins
EP-1277
> FMISO-PET and perfusion CT at baseline and week 2 CRT as
predictive markers for response in rectal cancer
T. Greenhalgh (UK), J. Wilson, T. Puri, J. Franklin, L. Wang, R. Goldin,
K. Chu, V. Strauss, M. Partridge, T. Maughan
EP-1278
> Tumour response after short course radiotherapy for rectal cancer:
immediate versus delayed surgery
M. Cruz (Portugal), C. Sousa, D. Branco, T. Serra, M. Areia, J. Brandão,
G. Melo
EP-1279
> Clinical outcomes of anal squamous cell carcinoma, treated with IMRT,
using UK guidance.
S. Sengupta (UK), S. Padmanaban, C. Jacobs, R. Muirhead
EP-1280
> Feasibility and toxicity analysis of dose-escalation by SIB/VMAT
schedule in rectal cancer patients
A. Re (Italy), G. Chiloiro, M.A. Gambacorta, F. Cellini, A. Pesce,
D. Marchesano, G.C. Mattiucci, S. Manfrida, V. Valentini
EP-1281
> Clinical and pathological prognostic factors in locally advanced rectal
cancer (LARC)